Key takeaway
This narrative review concludes that resistance training and adequate protein intake remain the cornerstone of managing age-related muscle loss, while newer approaches such as gene editing, stem cells and microbiome-directed diets show only early promise. It pools no data and gives no effect sizes, so it cannot say how much any of these strategies helps.
Study design
Research article
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
Sarcopenia, the gradual loss of muscle mass, strength and function, weighs heavily on health and quality of life in older adults. The authors set out to map both current and emerging ways to prevent or treat it, from muscle regeneration to the gut-muscle link.
Who and how
A narrative review: the authors summarised existing literature rather than running a systematic search. Topics covered muscle regeneration, mitochondrial function, nutritional strategies, the muscle-microbiome axis, and drug and lifestyle approaches aimed at anabolic resistance (a blunted muscle-building response) and the integrity of the neuromuscular junction. The abstract does not report how studies were found or selected, or any sample sizes.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Resistance training and adequate protein intake are described as the cornerstone of sarcopenia management.
- 2Emerging ideas for repairing muscle include activating satellite cells (muscle stem cells), targeting signalling pathways and controlling chronic inflammation. Gene editing, stem cell therapy and microRNA modulation are said to show promise for muscle repair.
- 3On the metabolic side, the review highlights improving mitochondrial biogenesis and ATP production and reducing oxidative stress.
- 4Nutrition options discussed include leucine supplementation, anti-inflammatory nutrients, dietary changes and probiotics aimed at the muscle-microbiome link; hydration and muscle-water balance are also emphasised as important for older adults.
Limits & uncertainty
- 1A narrative review has no stated search method, so the choice of studies may be selective and the strength of evidence behind each idea is not graded in the abstract.
- 2The abstract gives no numbers, so it is impossible to compare how large the benefit of training, protein or any emerging therapy is.
- 3Many of the newer strategies (gene editing, stem cells, microRNA, probiotics) are described as promising, which usually means early or preclinical evidence rather than proven benefit in older people.
- 4This reading is based on the abstract only.
What to take from it
The solid message is the familiar one: regular resistance training plus enough protein is the best-supported way to protect muscle with age. The newer therapies are research directions, not things to buy or try on the strength of this review. Anyone worried about muscle loss or considering supplements should discuss it with their clinician.
Reading your own data
Strength-training logs (sessions, load, repetitions), body weight and protein intake from a food log are the personal data closest to this topic. Compare your own numbers over weeks to months, using the same scale, gym setup and logging method, rather than judging single sessions.
How to read this evidence
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
Sarcopenia is characterized by the progressive loss of skeletal muscle mass, strength, and function, significantly impacting overall health and quality of life in older adults. This narrative review explores emerging targets and potential treatments for sarcopenia, aiming to provide a comprehensive overview of current and prospective interventions.
Methods
The review synthesizes current literature on sarcopenia treatment, focusing on recent advancements in muscle regeneration, mitochondrial function, nutritional strategies, and the muscle-microbiome axis. Additionally, pharmacological and lifestyle interventions targeting anabolic resistance and neuromuscular junction integrity are discussed.
Results
Resistance training and adequate protein intake remain the cornerstone of sarcopenia management. Emerging strategies include targeting muscle regeneration through myosatellite cell activation, signaling pathways, and chronic inflammation control. Gene editing, stem cell therapy, and microRNA modulation show promise in enhancing muscle repair. Addressing mitochondrial dysfunction through interventions aimed at improving biogenesis, ATP production, and reducing oxidative stress is also highlighted. Nutritional strategies such as leucine supplementation and anti-inflammatory nutrients, along with dietary modifications and probiotics targeting the muscle-microbiome interplay, are discussed as potential treatment options. Hydration and muscle-water balance are emphasized as critical in maintaining muscle health in older adults.
Conclusions
A combination of resistance training, nutrition, and emerging therapeutic interventions holds potential to significantly improve muscle function and overall health in the aging population. This review provides a detailed exploration of both established and novel approaches for the prevention and management of sarcopenia, highlighting the need for further research to optimize these strategies.
Sources & attribution
Emerging Targets and Treatments for Sarcopenia: A Narrative Review.
Cacciatore S, Calvani R, Esposito I, Massaro C, Gava G, Picca A, Tosato M, Marzetti E, Landi F.
Nutrients · 2024-09-27
DOI: 10.3390/nu16193271 ↗PubMed · 39408239 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
ACSM review of 137 reviews: resistance training works, and few programme details matter
The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.
Medicine & Science in Sports & Exercise
Nearly every resistance training plan beat no exercise; heavy loads led for strength
In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.
British Journal of Sports Medicine
Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes
Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.
British Journal of Sports Medicine
Protein supplements and weight training: small extra gains, smaller in older adults
Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.
British Journal of Sports Medicine

